News | Cardiovascular Business | January 12, 2017

9 Ways TrumpCare May Change the Healthcare Industry

Healthcare advisory firm predicts greater spending on information technology as a way to enhance value, more public/private partnerships

TrumpCare, 9 ways may change the healthcare industry, Vertess

January 12, 2017 — International healthcare-focused merger and acquisition (M+A) advisory firm Vertess recently shared its vision of how a new healthcare plan from President-elect Donald Trump could impact the healthcare industry. Their analysis can be found below:

At this point, two things are certain about TrumpCare: It's going to happen and it will dramatically affect the healthcare landscape. But what will it look like? At this point nobody knows, yet we can see the "tea leaves" in Trump's appointments and the statements that he and his appointees have made, as well as the various noises of Congress as they mull over "repeal and replace." There are nine likely developments:

1. Block Grants for Medicaid - President-elect Trump has already proposed significant tax cuts, which will add to the pressure to reduce healthcare expense. The brunt of this effort is most likely to fall upon Medicaid, probably in the form of block grants to states rather than direct federal funding.

2. More Emphasis on Value - Health insurers have long wanted to control costs by paying for results rather than activities, aka "value-based reimbursement." TrumpCare will probably require healthcare providers to embrace expensive technology to prove "demonstrated outcomes" before being paid.

3. More Spending on Information Technology - Increased emphasis on cost control and outcomes will drive healthcare providers to use more technology. Much of this will take the form of shifting care management onto patients.

4. Less Government Regulation - Trump and GOP have identified over-regulation as a major source of unnecessary healthcare costs. As such, TrumpCare will likely incorporate a reduction in regulations for healthcare providers, especially those promulgated during the Obama administration.  

5. Fewer Cost Controls for Physicians - The proposed Secretary of Health and Human Services (HHS), Tom Price, believes physicians should play a leadership role in all areas of healthcare, including reimbursement approaches outside of hospital settings. He can be expected to fight programs like the current Centers for Medicare and Medicaid Services (CMS) effort to bundle payments for cardio surgery.

6. More Public/Private Partnerships - Some public/private demonstration programs, like the Independence At Home (IAH) in-home elder primary care project, have yielded good results for shared risk and profitability.  

7. Accelerated Innovation – Everything from new gene therapies to population analytics will become more attractive as methods to deliver more targeted, cost-effective services and products. They are already disrupting the healthcare marketplace and they will attract even more investment with TrumpCare.

8. Greater Demand for Outpatient Healthcare – CMS and private payers will increase their reimbursement for outpatient medicine as an option to traditional hospital-based care creating more opportunities for entrepreneurs and significant challenges for hospitals.  

9. More Mergers and Acquisitions - Obamacare drove a wave of M+A activity as healthcare firms were forced to adapt to rapidly changing circumstances. TrumpCare is likely to create even more change, especially in fragmented areas of the healthcare market (mostly outside of hospitals).  

Tom Schramski, Vertess managing partner noted that, "Healthcare technology in all verticals will have more prominence and company value. Other factors that will impact value, including the emerging issues of minimum wage and the recently stayed increases in the exempt salary threshold advanced by the U.S. Department of Labor, will affect labor-intensive services, which predominate in the healthcare marketplace." 

For more information: www.vertess.com

Related Content

Leeds Hospital recently installed Philips Azurion angiography interventional labs to enhance procedural guidance capabilities.

Leeds Hospital recently installed Philips Azurion angiography interventional labs to enhance procedural guidance capabilities.

News | Cardiovascular Business | July 08, 2020
July 8, 2020 – Philips Healthcare and Leeds Teaching Hospitals NHS Trust announced a seven-year managed service agree
Medicare will pay for telehealth virtual doctor visits during the duration of the coronavirus COVID-19 outbreak.
News | Cardiovascular Business | March 17, 2020
March 17, 2020 — The Trump Administration today announced expanded Medicare telehealth coverage that will enable bene
Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Cardiovascular Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
 Cath Lab Philips Azurion angiography PCI
News | Cardiovascular Business | December 30, 2019
December 30, 2019 — Most patients do not understand or recall information given to them before heart procedures.
Siemens Healthineers Acquires ECG Management Consultants
News | Cardiovascular Business | November 11, 2019
November 11, 2019 — ECG Management Consultants, a leading U.S.
Videos | Cardiovascular Business | September 30, 2019
A discussion with Ruth Fisher, MBA, vice president of the...
Scranton Gillette Communications Names Diagnostic and Interventional Cardiology Group Publisher and Integrated Media Consultant

Diane Vojcanin (left) was named vice president, group publisher, healthcare group, overseeing Imaging Technology News (ITN) and Diagnostic and Interventional Cardiology (DAIC). Andreja Slapsys (right) was named a healthcare group integrated media consultant.

News | Cardiovascular Business | September 06, 2019
Business-to-business communications company Scranton Gillette Communications has named Diane Vojcanin as vice president...
FDA Opens Proposal Solicitation Period for 2020 Experiential Learning Program
News | Cardiovascular Business | July 17, 2019
The U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) announced the 2020...